Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVietnam Enterprise Investments Regulatory News (VEIL)

Share Price Information for Vietnam Enterprise Investments (VEIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 591.00
Bid: 589.00
Ask: 591.00
Change: 5.00 (0.85%)
Spread: 2.00 (0.34%)
Open: 583.00
High: 592.00
Low: 583.00
Prev. Close: 586.00
VEIL Live PriceLast checked at -
Vietnam Enterprise Investments is an Investment Trust

To invest directly or indirectly in publicly or privately issued securities of companies, projects and enterprises issued by Vietnamese entities, whether inside or outside Vietnam.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Vietnam Enterprise Investments

19 Nov 2019 11:51

RNS Number : 9263T
Vietnam Enterprise Investments Ltd
19 November 2019
 

 

London, UK, 19 November 2019

Edison issues review on Vietnam Enterprise Investments (VEIL)

Vietnam Enterprise Investments (VEIL) is the largest and longest-established closed-end fund focused on investing in Vietnamese equities. The fund aims to deliver long-term capital growth through employing a rigorous bottom-up approach to investing in a relatively concentrated portfolio of 35-40 high-conviction stocks. Over the past 10 years, VEIL has generated annualised NAV and share price returns of 10.3% and 14.0%, respectively. Better than expected Q319 GDP growth of 7.3% suggests Vietnam's economy is relatively resilient in an environment of slowing global economic growth, which has been exacerbated by a trade recession triggered by the US-China trade dispute. Furthermore, the manager is finding plenty of exciting long-term investment opportunities in Vietnam.

 

VEIL currently trades at a 9.9% discount to NAV, which is narrower than its three-year average of 14.1%. The board actively monitors the discount and has the ability to manage an imbalance of supply and demand for VEIL's shares when deemed to be in shareholders' best interests. Focused on capital growth, the fund has not paid a dividend since its inception.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Helena Coles, +44 (0)20 3681 2522

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRADMMMMMLRGLZM
Date   Source Headline
6th Feb 20247:00 amRNSNet Asset Value(s)
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSNet Asset Value(s)
2nd Feb 20247:00 amRNSCompany Presentation
2nd Feb 20247:00 amRNSNet Asset Value(s)
1st Feb 202412:32 pmRNSStatement re change in Portfolio Management Team
1st Feb 20247:00 amRNSNet Asset Value(s)
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSNet Asset Value(s)
30th Jan 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSFourth Quarter Update
29th Jan 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSNet Asset Value(s)
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSNet Asset Value(s)
24th Jan 20247:00 amRNSNet Asset Value(s)
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSNet Asset Value(s)
22nd Jan 20247:00 amRNSNet Asset Value(s)
19th Jan 20247:00 amRNSNet Asset Value(s)
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSNet Asset Value(s)
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSNet Asset Value(s)
16th Jan 20247:00 amRNSNet Asset Value(s)
15th Jan 20247:00 amRNSNet Asset Value(s)
15th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSMonthly Update
12th Jan 20247:00 amRNSNet Asset Value(s)
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSNet Asset Value(s)
10th Jan 20247:00 amRNSNet Asset Value(s)
9th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSNet Asset Value(s)
8th Jan 20249:53 amRNSNet Asset Value(s)
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSNet Asset Value(s)
4th Jan 20247:00 amRNSNet Asset Value(s)
3rd Jan 202412:28 pmRNSNet Asset Value(s)
2nd Jan 20247:00 amRNSNet Asset Value(s)
29th Dec 20237:00 amRNSNet Asset Value(s)
28th Dec 20237:00 amRNSNet Asset Value(s)
27th Dec 20237:00 amRNSNet Asset Value(s)
27th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSNet Asset Value(s)
22nd Dec 20237:00 amRNSNet Asset Value(s)
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.